Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

NCT04517838 · clinicaltrials.gov ↗

RECRUITING

Status

230

Enrollment

OTHER

Sponsor class

Conditions

Breast Adenocarcinoma
HER2-Positive Breast Carcinoma
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection

Sponsor

Mayo Clinic